rs74477879

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000259698.9(RIPOR2):​c.1146C>G​(p.Phe382Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00531 in 1,551,674 control chromosomes in the GnomAD database, including 220 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 125 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 95 hom. )

Consequence

RIPOR2
ENST00000259698.9 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.74

Publications

3 publications found
Variant links:
Genes affected
RIPOR2 (HGNC:13872): (RHO family interacting cell polarization regulator 2) This gene encodes an atypical inhibitor of the small G protein RhoA. Inhibition of RhoA activity by the encoded protein mediates myoblast fusion and polarization of T cells and neutrophils. The encoded protein is a component of hair cell stereocilia that is essential for hearing. A splice site mutation in this gene results in hearing loss in human patients. [provided by RefSeq, Sep 2016]
RIPOR2 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 104
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant nonsyndromic hearing loss 21
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014749169).
BP6
Variant 6-24847623-G-C is Benign according to our data. Variant chr6-24847623-G-C is described in ClinVar as Benign. ClinVar VariationId is 509125.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0696 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RIPOR2NM_001286445.3 linkc.1164+402C>G intron_variant Intron 12 of 21 ENST00000643898.2 NP_001273374.1 A0A2R8YEE0B7Z5J9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RIPOR2ENST00000643898.2 linkc.1164+402C>G intron_variant Intron 12 of 21 NM_001286445.3 ENSP00000494268.2 A0A2R8YEE0

Frequencies

GnomAD3 genomes
AF:
0.0214
AC:
3254
AN:
152196
Hom.:
123
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0718
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00700
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00195
Gnomad OTH
AF:
0.0162
GnomAD2 exomes
AF:
0.00515
AC:
805
AN:
156436
AF XY:
0.00438
show subpopulations
Gnomad AFR exome
AF:
0.0705
Gnomad AMR exome
AF:
0.00482
Gnomad ASJ exome
AF:
0.000118
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000179
Gnomad NFE exome
AF:
0.00190
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00356
AC:
4980
AN:
1399360
Hom.:
95
Cov.:
31
AF XY:
0.00322
AC XY:
2223
AN XY:
690188
show subpopulations
African (AFR)
AF:
0.0756
AC:
2387
AN:
31592
American (AMR)
AF:
0.00504
AC:
180
AN:
35704
Ashkenazi Jewish (ASJ)
AF:
0.0000397
AC:
1
AN:
25182
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35738
South Asian (SAS)
AF:
0.000139
AC:
11
AN:
79236
European-Finnish (FIN)
AF:
0.000568
AC:
28
AN:
49266
Middle Eastern (MID)
AF:
0.00579
AC:
33
AN:
5698
European-Non Finnish (NFE)
AF:
0.00185
AC:
2000
AN:
1078926
Other (OTH)
AF:
0.00586
AC:
340
AN:
58018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
243
486
728
971
1214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0214
AC:
3261
AN:
152314
Hom.:
125
Cov.:
32
AF XY:
0.0198
AC XY:
1477
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0718
AC:
2983
AN:
41556
American (AMR)
AF:
0.00699
AC:
107
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00196
AC:
133
AN:
68030
Other (OTH)
AF:
0.0161
AC:
34
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
157
314
470
627
784
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00464
Hom.:
12
Bravo
AF:
0.0244
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00156
AC:
6
ExAC
AF:
0.00724
AC:
188
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 24, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Oct 23, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
17
DANN
Benign
0.79
DEOGEN2
Benign
0.00069
T;T;T;.
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.20
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.53
.;T;.;T
MetaRNN
Benign
0.0015
T;T;T;T
MetaSVM
Benign
-0.91
T
PhyloP100
2.7
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.040
.;.;N;.
REVEL
Benign
0.035
Sift
Benign
0.70
.;.;T;.
Sift4G
Benign
0.70
.;T;T;.
Polyphen
0.0
B;B;B;.
Vest4
0.081, 0.069
MutPred
0.31
Loss of solvent accessibility (P = 0.001);Loss of solvent accessibility (P = 0.001);Loss of solvent accessibility (P = 0.001);Loss of solvent accessibility (P = 0.001);
MVP
0.10
MPC
0.35
ClinPred
0.0087
T
GERP RS
4.3
Varity_R
0.089
gMVP
0.37
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74477879; hg19: chr6-24847851; COSMIC: COSV52419202; COSMIC: COSV52419202; API